reclogging

As many as 40 percent of people who receive older "bare metal" stents experience reclogging of the artery, usually within six months of the surgery.

Q&A: How common is stent failure? 2009

As many as 40 percent of people who receive older "bare metal" stents experience reclogging of the artery, usually within six months of the surgery.

Q&A: How common is stent failure? 2009

Such coated stents help prevent arteries from reclogging after a stent is implanted.

J&J Wins Stent Patent Appeal Against Boston Scientific 2009

Stents are small scaffolds used to prop open blocked blood vessels, and some are coated with a medication that prevents reclogging.

Abbott's Xience Stent 2008

Boston Scientific has promoted the Liberte as easier to implant than Express and just as good at preventing arteries from reclogging after implantation.

Boston Scientific Stent Wins Approval 2008

Models coated with drugs to reduce reclogging, from Boston Scientific Corp., of Natick, Mass., and Johnson & Johnson, of New Brunswick, N.J., account for most of the U.S. market.

FDA Proposes Stent Guidelines 2008

Drug-coated stents are designed to prevent scar tissue from reclogging the artery later and thus reduce the need for patients to return for a repeat operation.

Health Firms to Study Clots in Stent Patients 2008

Taxus is coated with drugs that reduce reclogging and is the top-selling model world-wide, with $1.8 billion in sales last year.

Heart Surgery 2008

The lucrative, tiny devices are inserted during angioplasty procedures to prop open heart arteries; they use medication to fight reclogging.

Boston Scientific Net Falls, 2008

The fanciest, most profitable kind -- those coated with drugs to prevent reclogging -- were used in 88% of stentings as recently as mid-2006.

Coated Stents' Market Stabilizes 2008